Globus Medical Inc (GMED) reported better-than-expected financial results for the third quarter of fiscal 2025. The company achieved earnings per share (EPS) of $1.18, significantly surpassing Wall Street's consensus estimate of $0.80 by $0.38. Revenue reached $0.8 billion, exceeding expectations of $0.7 billion.
This update provides insight into Globus Medical's recent operational performance and financial health. The company, headquartered in Audubon, Pennsylvania, specializes in developing and commercializing healthcare solutions, particularly in the musculoskeletal sector. With a market cap of $8,333.95 million and a trailing P/E ratio of 23.37, Globus Medical employs approximately 5,300 full-time staff.
The company will host its earnings conference call after market close to discuss these results and provide further commentary on its business performance. Investors are encouraged to review the full earnings release and listen to management’s insights for a complete context on the quarter's performance and future outlook.
Looking ahead, analysts anticipate EPS of $0.8621 and revenue of $0.7 billion for the upcoming earnings report on April 30, 2026, while the next report on February 9, 2026, is expected to show EPS of $1.0078 and revenue of $0.8 billion.